MEAGHAN DEVENS: Open Payments
NPI 1194566331 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 35 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $311 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $212 |
| Lilly USA, LLC | 7 | $152 |
| Novo Nordisk Inc | 3 | $60 |
| PFIZER INC. | 2 | $52 |
| Amgen Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: MOUNJARO, AIRSUPRA, NURTEC ODT, OTEZLA, Ozempic, GARDASIL 9, FARXIGA, Rybelsus.
Industry payments across VA — which companies pay providers there.
